Estrogen receptors in human disease

Archives of Toxicology

Volumn 86, Issue 10, 2012, Pages 1489-1490

  Cadenas, C ^a   Bolt, H M ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MICRORNA; TAMOXIFEN;

BREAST CANCER; CANCER PROGNOSIS; CARDIOVASCULAR DISEASE; DYSMENORRHEA; EDITORIAL; ENDOMETRIOSIS; FEMALE INFERTILITY; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

DISEASE; GENE EXPRESSION; HUMANS; RECEPTORS, ESTROGEN;

EID: 84866537702     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-012-0928-x     Document Type: Editorial

References (13)

1. Bolt HM, Stewart JD (2011) Highlight report: The bisphenol A controversy. Arch Toxicol 85(12):1491-1492
2. Brase JC, Schmidt M, Fischbach T, Sultmann H, Bojar H, Koelbl H, Hellwig B, Rahnenfuhrer J, Hengstler JG, Gehrmann MC (2010) ERBB2 and TOP2A in breast cancer: A comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction. Clin Cancer Res 16(8):2391-2401
3. Burns KA and Korach KS (2012) Estrogen receptors and human disease: An update. doi:10.1007/s00204-012-0868-5; this issue
4. Cadenas C, Franckenstein D, Schmidt M, Gehrmann M, Hermes M, Geppert B, Schormann W, Maccoux LJ, Schug M, Schumann A, Wilhelm C, Freis E, Ickstadt K, Rahnenfuhrer J, Baumbach JI, Sickmann A, Hengstler JG (2010) Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res 12(3):R44
5. Hengstler JG, Foth H, Gebel T, Kramer PJ, Lilienblum W, Schweinfurth H, Volkel W, Wollin KM, Gundert-Remy U (2011) Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol 41(4): 263-291
6. Hofer N, Diel P, Wittsiepe J, Wilhelm M, Kluxen FM, Degen GH (2010) Investigations on the estrogenic activity of the metallohormone cadmium in the rat intestine. Arch Toxicol 84(7): 541-552
7. Kammers K, Lang M, Hengstler JG, Schmidt M, Rahnenfuhrer J (2011) Survival models with preclustered gene groups as covariates. BMC Bioinformatics 12:478
8. Petry IB, Fieber E, Schmidt M, Gehrmann M, Gebhard S, Hermes M, Schormann W, Selinski S, Freis E, Schwender H, Brulport M, Ickstadt K, Rahnenfuhrer J, Maccoux L, West J, Kolbl H, Schuler M, Hengstler JG (2010) ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer. Clin Cancer Res 16(2):451-460
9. Romano RM, Romano MA, Bernardi MM, Furtado PV, Oliveira CA (2010) Prepubertal exposure to commercial formulation of the herbicide glyphosate alters testosterone levels and testicular morphology. Arch Toxicol 84(4):309-317
10. Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kolbl H, Gehrmann M (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68(13):5405-5413
11. Schmidt M, Victor A, Bratzel D, Boehm D, Cotarelo C, Lebrecht A, Siggelkow W, Hengstler JG, Elsasser A, Gehrmann M, Lehr HA, Koelbl H, von Minckwitz G, Harbeck N, Thomssen C (2009) Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer-comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Ann Oncol 20(2):258-264
12. Schmidt M, Petry IB, Bohm D, Lebrecht A, von Torne C, Gebhard S, Gerhold-Ay A, Cotarelo C, Battista M, Schormann W, Freis E, Selinski S, Ickstadt K, Rahnenfuhrer J, Sebastian M, Schuler M, Koelbl H, Gehrmann M, Hengstler JG (2011) Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer. Breast Cancer Res Treat 125(3):637-646
13. Schmidt M, Hellwig B, Hammad S, Othman A, Lohr M, Chen Z, Boehm D, Gebhard S, Petry I, Lebrecht A, Cadenas C, Marchan R, Stewart JD, Solbach C, Holmberg L, Edlund K, Kultima HG, Rody A, Berglund A, Lambe M, Isaksson A, Botling J, Karn T, Muller V, Gerhold-Ay A, Cotarelo C, Sebastian M, Kronenwett R, Bojar H, Lehr HA, Sahin U, Koelbl H, Gehrmann M, Micke P, Rahnenfuhrer J, Hengstler JG (2012) A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin j C as a compatible prognostic marker in human solid tumors. Clin Cancer Res 18(9):2695-2703